Stockscreener 앱 받기
30.50
0.10%
-0.03
시간 외 거래:
30.50
Indivior Pharmaceuticals Inc 주식(INDV)의 최신 뉴스
Indivior outlines 30% adjusted EBITDA growth target for 2026 with new $400M share repurchase program - MSN
Indivior Pharmaceuticals to report Q4 earnings: What's in the cards? - MSN
Indivior Issues $500 Million Convertible Senior Notes Offering - TipRanks
[Form 4] Indivior Pharmaceuticals, Inc. Insider Trading Activity - Stock Titan
Indivior Pharmaceuticals Raises $500 Million Via 0.625% Convertible Notes Due 2031 - TradingView
Implied volatility surging for Indivior Pharmaceuticals stock options - MSN
Indivior Pharmaceuticals Survey Reveals Gaps in Medications for Opioid Use Disorder in U.S. Jails and Prisons - Quiver Quantitative
Indivior plans $400M convertible senior notes offering - MSN
Indivior plans $400 million convertible notes offering By Investing.com - Investing.com Nigeria
Does Indivior’s Upsized Convertible Notes and Buybacks Shift the Bull Case For Indivior (INDV)? - simplywall.st
How Indivior’s Upsized $450 Million Convertible Notes and Buybacks May Impact Indivior (INDV) Investors - Yahoo Finance
Indivior director Kingsley buys $29,953 in shares By Investing.com - Investing.com Nigeria
Is It Too Late To Consider Indivior Pharmaceuticals (INDV) After A 221% One Year Surge? - simplywall.st
Indivior prices $450 million convertible notes offering By Investing.com - Investing.com Australia
Insider Buying: Barbara Ryan Acquires Shares of Indivior Pharmac - GuruFocus
Indivior Pharmaceuticals prices upsized $450M convertible senior notes - MSN
INDV SEC FilingsIndivior Pharmaceuticals Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Indivior PLC Stock (ISIN: US45580R1068) Drops 6% as $450M Convertible Notes Offering Signals Capital - AD HOC NEWS
Analysts Are Bullish on These Healthcare Stocks: Indivior (INDV), Gyre Therapeutics (GYRE) - The Globe and Mail
Indivior Prices Upsized Convertible Notes for Debt Refinancing - TipRanks
Indivior prices upsized $450M 0.625% convertible notes due 2031 - TradingView
Indivior (INDV) Upsizes Convertible Notes Offering to $450M - GuruFocus
Indivior Prices Upsized $450 Million Senior Notes Offering - marketscreener.com
Indivior Announces Proposed Convertible Senior Notes Offering - Sahm
Indivior Prices $450 Million Convertible Senior Notes Offering - National Today
Indivior (INDV) Plans $400 Million Convertible Notes Offering - GuruFocus
Indivior Prices Upsized $450.0 Million Convertible Senior Notes Offering - GlobeNewswire
Indivior plans $400 million convertible notes offering - Investing.com South Africa
Indivior prices $450 million convertible notes offering - Investing.com
Indivior Pharmaceuticals Announces Pricing of $450 Million Convertible Senior Notes Offering - Quiver Quantitative
Indivior proposes $400M convertible senior notes due 2031 to refinance debt, fund buybacks - TradingView
Indivior Announces $400 Million Convertible Notes and Buyback - TipRanks
Indivior stock falls after convertible notes offering announced - Investing.com
Indivior (Nasdaq: INDV) to issue $400M convertible notes and repay debt - Stock Titan
Indivior (NASDAQ: INDV) prices 0.625% convertible senior notes due 2031 - Stock Titan
Opioid Use Disorder Market Booming with Rapid Growth Through 2033 | Indivior PLC • Alkermes • Orexo AB - openPR.com
Indivior director Kingsley buys $29,953 in shares - Investing.com Australia
Indivior (NASDAQ:INDV) Director Stuart Kingsley Buys 940 Shares - MarketBeat
Indivior (INDV) Study: Sublocade Reduces Healthcare Costs for OU - GuruFocus
New Study Shows Adherence to Monthly Injectable - GlobeNewswire
Ryan Barbara buys Indivior (INDV) shares worth $1,009 By Investing.com - Investing.com South Africa
Ryan Barbara buys Indivior (INDV) shares worth $1,009 - Investing.com
Victory Capital Management Inc. Makes New $19.44 Million Investment in Indivior PLC $INDV - MarketBeat
2.02%
0.77%
자본화:
|
볼륨(24시간):